home All News open_in_new Full Article

EE. UU. revoca licencia a vacuna contra chikungunya por efectos secundarios en adultos mayores

El fabricante de la vacuna anunció la suspensión inmediata de la licencia extendida por la FDA, debido a efectos secundarios graves reportados en adultos mayores de 70 años.


today 1 week ago attach_file Other

attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other


ID: 3029913388
Add Watch Country

arrow_drop_down